This paper is in the following e-collection/theme issue:

mHealth for Symptom and Disease Monitoring, Chronic Disease Management (1399) Apps, Mobile, Wearables for Diabetes (298) Glucose Tracking and Self-Monitoring of Blood Glucose (162)

Published on in Vol 8, No 3 (2020): March

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/15390, first published .
A Mobile-Based Intervention for Glycemic Control in Patients With Type 2 Diabetes: Retrospective, Propensity Score-Matched Cohort Study

A Mobile-Based Intervention for Glycemic Control in Patients With Type 2 Diabetes: Retrospective, Propensity Score-Matched Cohort Study

A Mobile-Based Intervention for Glycemic Control in Patients With Type 2 Diabetes: Retrospective, Propensity Score-Matched Cohort Study

Authors of this article:

Jing Li1 Author Orcid Image ;   Li Sun2 Author Orcid Image ;   Yaogang Wang3 Author Orcid Image ;   Lichuan Guo1 Author Orcid Image ;   Daiqing Li1 Author Orcid Image ;   Chang Liu4 Author Orcid Image ;   Ning Sun5 Author Orcid Image ;   Zheng Xu5 Author Orcid Image ;   Shu Li3 Author Orcid Image ;   Yunwen Jiang3 Author Orcid Image ;   Yuan Wang3 Author Orcid Image ;   Shunming Zhang3 Author Orcid Image ;   Liming Chen1 Author Orcid Image
Article Authors Cited by (9) Tweetations (2) Metrics

Jing Li   1 * , PhD ;   Li Sun   2 * , PhD ;   Yaogang Wang   3 * , PhD ;   Lichuan Guo   1 , MA ;   Daiqing Li   1 , PhD ;   Chang Liu   4 , BS ;   Ning Sun   5 , MBA ;   Zheng Xu   5 , MD ;   Shu Li   3 , PhD ;   Yunwen Jiang   3 , BS ;   Yuan Wang   3 , PhD ;   Shunming Zhang   3 , MD ;   Liming Chen   1 , PhD

1 National Health Commission Key Laboratory of Hormones and Development, Tianjin Key Laboratory of Metabolic Diseases, Chu Hsien-I Memorial Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, China

2 School of Nursing, Tianjin Medical University, Tianjin, China

3 School of Public Health, Tianjin Medical University, Tianjin, China

4 Yiducloud Technologies Co, Ltd, Beijing, China

5 Yu-Tang Department, iHealth Labs Inc, Beijing, China

*these authors contributed equally

Corresponding Author:

  • Liming Chen, PhD
  • National Health Commission Key Laboratory of Hormones and Development, Tianjin Key Laboratory of Metabolic Diseases
  • Chu Hsien-I Memorial Hospital & Tianjin Institute of Endocrinology
  • Tianjin Medical University
  • No 6, Huanruibei Road, Beichen District
  • Tianjin, 300134
  • China
  • Phone: 86 13920979401
  • Email: xfx22081@vip.163.com